P.J. Klasse, MD, PhD

Highlights

1
PLoS pathogens · 2023
JPJohn P Moore PKP.J. Klasse
PMID: 37903160PMCID: PMC10635575DOISenior author12 citations
2
Retrovirology · 2023
JPJohn P Moore PKP.J. Klasse
PMID: 37244989PMCID: PMC10221750DOISenior author7 citations

193

6 grants

Co-I
Targeting germline-bNAbs via SOSIP trimers;
National Institute of Allergy and Infectious Diseases · 2026–2031
P01AI197052-01
Co-I
Neutralization of primary HIV-1 viruses
National Institute of Allergy and Infectious Diseases · 2018–2028· 2 renewals
R01AI036082-31
Co-I
INV63951 - Trimer based germline-targeting immunization to induce HIV-1 bNAbs - AUMC
Bill & Melinda Gates Foundation · 2025–2026 · via Amsterdam University Medical Centers
INV-063951
Co-I
Cleaved, stabilized HIV-1 Env trimers for structural and vaccine studies
National Institute of Allergy and Infectious Diseases · 2020–2026· 2 renewals
P01AI110657-10 CORE A
Co-I
INV091003 Targeting germline-bNAbs via SOSIP trimers
Bill & Melinda Gates Foundation · 2025–2026
BMGF INV-091003
Co-I
Phase 1 study of BG505 SOSIP Trimer boosting in GT1.1 primed individuals
Bill & Melinda Gates Foundation · 2023–2025 · via Rockefeller University
INV-048573

Completed grants (2)

Co-I
Phase 1 clinical study testing GT1.1 trimer
Bill & Melinda Gates Foundation · 2019–2024 · via Rockefeller University
INV-008818
Co-I
Neutralization of Primary HIV-1 Viruses
National Institute of Allergy and Infectious Diseases · 2013–2018
R37AI036082-25

The Quest for an HIV Vaccine
August 20, 2025
Along with an international team, Dr. John Moore, has brought biomedicine closer than ever to an HIV vaccine.